Literature DB >> 6330083

Protein-primed replication of plasmids containing the terminus of the adenovirus genome. II. Purification and characterization of a host protein required for the replication of DNA templates devoid of the terminal protein.

R A Guggenheimer, K Nagata, M Kenny, J Hurwitz.   

Abstract

A host protein, which is required for the replication of a plasmid DNA (pLA1), has been purified from extracts of uninfected HeLa nuclei. This plasmid DNA contains the origin of adenovirus DNA replication but lacks the 55,000-dalton terminal proteins. The purified host protein has been designated factor pL. Factor pL is essential for the initiation of DNA replication of EcoRI-digested pLA1 DNA, which proceeds via the formation of a covalent complex between the 80,000-dalton adenovirus coded preterminal protein and 5' dCMP. Factor pL has been purified approximately 120-fold to greater than 75% homogeneity. It is a heat labile and N-ethylmaleimide-sensitive protein with a native Mr = 39,000 (+/- 2,000). Initiation of DNA replication using EcoRI-digested pLA1 DNA as the template requires the 80,000-dalton preterminal protein and the 140,000-dalton adenovirus DNA polymerase, in addition to factor pL, and is stimulated as much as 10-fold by nuclear factor I ( Nagata , K., Guggenheimer , R. A., Enomoto , T., Lichy , J. H., and Hurwitz , J. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 6438-6442). Factor pL has no effect on in vitro DNA replication when adenovirus DNA covalently linked to the 55,000-dalton terminal protein is used as the template, however the replication of adenovirus DNA treated with Pronase, becomes totally dependent upon the addition of factor pL.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330083

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Improved production of gutted adenovirus in cells expressing adenovirus preterminal protein and DNA polymerase.

Authors:  D Hartigan-O'Connor; A Amalfitano; J S Chamberlain
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

Review 2.  Recognition mechanisms in the synthesis of animal virus DNA.

Authors:  R T Hay; W C Russell
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

3.  DNA binding properties of the adenovirus DNA replication priming protein pTP.

Authors:  R N de Jong; L A T Meijer; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

4.  Codon insertion mutants of the adenovirus terminal protein.

Authors:  P I Freimuth; H S Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

5.  The adenovirus terminal protein influences binding of replication proteins and changes the origin structure.

Authors:  R Pronk; P C van der Vliet
Journal:  Nucleic Acids Res       Date:  1993-05-25       Impact factor: 16.971

6.  Expression in Escherichia coli of a fusion protein product containing a region of the adenovirus DNA polymerase.

Authors:  D Rekosh; J Lindenbaum; J Brewster; L M Mertz; J Hurwitz; L Prestine
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

Review 7.  Flap endonuclease 1.

Authors:  Lata Balakrishnan; Robert A Bambara
Journal:  Annu Rev Biochem       Date:  2013-02-28       Impact factor: 23.643

8.  Generation of single-nucleotide repair patches following excision of uracil residues from DNA.

Authors:  G Dianov; A Price; T Lindahl
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

9.  Identification of two distinct regions within the adenovirus minimal origin of replication that are required for adenovirus type 4 DNA replication in vitro.

Authors:  S M Temperley; C R Burrow; T J Kelly; R T Hay
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

10.  Analysis of the adenovirus type 5 terminal protein precursor and DNA polymerase by linker insertion mutagenesis.

Authors:  D J Roovers; F M van der Lee; J van der Wees; J S Sussenbach
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.